1.3460
-0.0230
(-1.68%)
At close: 8:37:14 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
85,588.0000
149,840.0000
105,573.0000
76,715.0000
31,285.0000
Operating Income
-85,588.0000
-149,840.0000
-105,573.0000
-76,715.0000
-31,285.0000
Net Non Operating Interest Income Expense
-1,228.0000
-204.0000
-247.0000
-105.0000
-39.0000
Pretax Income
-161,048.0000
-224,275.0000
-107,066.0000
-76,809.0000
-31,304.0000
Tax Provision
-6,482.0000
-8,466.0000
-7,860.0000
-7,505.0000
-4,753.0000
Net Income Common Stockholders
-154,566.0000
-215,810.0000
-99,205.0000
-69,304.0000
-26,551.0000
Diluted NI Available to Com Stockholders
-154,566.0000
-215,810.0000
-99,205.0000
-69,304.0000
-26,551.0000
Basic EPS
-4.84
-6.64
-3.60
-2.68
-1.18
Diluted EPS
-4.84
-6.64
-3.60
-2.68
-1.18
Basic Average Shares
35,478.3550
32,523.8550
27,585.0010
25,848.4870
22,556.4630
Diluted Average Shares
35,478.3550
32,523.8550
27,585.0010
25,848.4870
22,556.4630
Total Operating Income as Reported
-160,245.0000
-224,496.0000
-105,705.0000
-76,699.0000
-31,285.0000
Total Expenses
85,588.0000
149,840.0000
105,573.0000
76,715.0000
31,285.0000
Net Income from Continuing & Discontinued Operation
-154,566.0000
-215,810.0000
-99,205.0000
-69,304.0000
-26,551.0000
Normalized Income
-83,008.8752
-69,508.4378
-99,205.0000
-69,304.0000
-26,551.0000
Interest Income
--
593.0000
47.0000
--
30.0000
Interest Expense
--
797.0000
294.0000
105.0000
39.0000
Net Interest Income
-1,228.0000
-204.0000
-247.0000
-105.0000
-39.0000
EBIT
-159,226.0000
-223,478.0000
-106,772.0000
-76,704.0000
-31,265.0000
EBITDA
-159,226.0000
-148,142.0000
-105,754.0000
-76,616.0000
-31,265.0000
Reconciled Depreciation
--
75,336.0000
1,018.0000
88.0000
--
Net Income from Continuing Operation Net Minority Interest
-154,566.0000
-215,810.0000
-99,205.0000
-69,304.0000
-26,551.0000
Total Unusual Items Excluding Goodwill
-74,558.0000
-74,558.0000
--
--
--
Normalized EBITDA
-159,226.0000
-148,142.0000
-105,754.0000
-76,616.0000
-31,265.0000
Tax Rate for Calcs
0.0000
0.0000
0.0001
0.0001
0.0002
Tax Effect of Unusual Items
-3,000.8752
-2,814.4378
--
--
--
12/31/2020 - 7/20/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6Y4.F Vicore Pharma Holding AB (publ)
0.7310
-2.14%
HQ1.MU Oruka Therapeutics Inc. R
11.20
+3.70%
ICY.SG Incyte Corp
66.72
+1.15%
REGN.MX Regeneron Pharmaceuticals, Inc.
13,757.24
+0.80%
PH4.F CStone Pharmaceuticals
0.3060
-2.55%
605116.SS Aurisco Pharmaceutical Co.,Ltd.
19.75
-2.08%
22UA.DU BioNTech SE
112.70
+4.35%
ALGEN.PA genOway Société anonyme
3.5400
+2.31%
0WA2.IL Cellectis S.A.
1.5200
0.00%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3310
+0.61%